InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Whalatane post# 28579

Monday, 06/02/2014 6:48:45 PM

Monday, June 02, 2014 6:48:45 PM

Post# of 427507
We agree. I just said the the CAP is not enough: more control on cost and increase script #.

Based on available info, forecast, etc. currently guess +/-0 CF in Q215.

R-IT: Meanwhile hope that JL has right, I agree w u: it's not a simple math.

2 small piece for R-IT:
- 'All DMC meeting to date have recommended continuation of study as planned' (page 69) and
- I know it's a small chart without data (and we do not know the reason for it), however check the blue line position compared w pink ... (page 73)

http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM371763.pdf

(Since last week I missed NRx by -4 and Refill by +100, my bet for this week: NRx - 3,672, Refill - 4,260, TRx - 7,932)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News